Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection

被引：7
|
作者：
Bai, Ya Mei [1 ]
Chen, Tzu Ting
Lin, Wen Kuo
Chang, Wen-Ho
Wu, Bojian
Hung, Chih Hung
Chou, Pesus
Chen, Jen-Yeu
机构：
[1] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[2] Yu Li Vet Hosp, Dept Psychiat, Hualien, Taiwan
[3] Kaohsiung Med Univ, Grad Inst Behav Sci, Kaohsiung, Taiwan
[4] Buddhist Tzu Chi Gen Hosp, Dept Psychiat, Da Lin, Taiwan
[5] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol, Taipei 10764, Taiwan
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2007年 / 27卷 / 03期
关键词：
D O I：
10.1097/01.jcp.0000270090.55156.7a
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：306 / 308
页数：3
相关论文
共 50 条
  • [31] Risperidone long-acting injection: a one year observational study in a naturalistic setting
    Patel, M. X.
    Young, C.
    David, A. S.
    Taylor, D. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S369 - S370
  • [32] Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
    Hori, Hikaru
    Katsuki, Asuka
    Atake, Kiyokazu
    Yoshimura, Reiji
    FRONTIERS IN PSYCHIATRY, 2018, 9
  • [33] Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection
    Lasser, RA
    Bossie, CA
    Gharabawi, GM
    Kane, JM
    SCHIZOPHRENIA RESEARCH, 2005, 77 (2-3) : 215 - 227
  • [34] Long-acting risperidone:: Focus on safety
    Mueller, Hans-Juergen
    CLINICAL THERAPEUTICS, 2006, 28 (05) : 633 - 651
  • [35] Efficacy and safety of long-acting risperidone microspheres and risperidone oral tables
    Chue, P
    Eerdekens, M
    Augustyns, I
    Lachaux, B
    Molcan, P
    Eriksson, L
    Pretorius, H
    David, A
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 174 - 175
  • [36] Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets
    Chue, P
    Eerdekens, M
    Augustyns, I
    Lachaux, B
    Molcan, P
    Eriksson, L
    Pretorius, H
    David, AS
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (01) : 111 - 117
  • [37] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [38] RISPERIDONE LONG-ACTING INJECTION VS. CONVENTIONAL DEPOT INJECTIONS
    Jensen, S. O. W.
    Nielsen, J.
    Friis, R.
    Correll, C. U.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [39] Risperidone long-acting injection: A systematic review of UK naturalistic studies
    Patel, MX
    Young, C
    Taylor, DM
    David, AS
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A15 - A15
  • [40] To Ingest or Inject? A report of oral ingestion of risperidone long-acting injection
    Montague, Abby
    Laes, JoAn
    CLINICAL TOXICOLOGY, 2017, 55 (07) : 741 - 742
12345